• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素使用与耐药性之间的关联:次级抗生素的作用。

The association between antibiotic use and resistance: the role of secondary antibiotics.

机构信息

Department of Clinical Pharmacy and Outcome Sciences, South Carolina College of Pharmacy-MUSC Campus, MSC 140, Charleston, SC 29425, USA.

出版信息

Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1125-9. doi: 10.1007/s10096-010-0972-5. Epub 2010 Jun 10.

DOI:10.1007/s10096-010-0972-5
PMID:20535624
Abstract

Using susceptibility rates of Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae over time as markers, we assessed the significance of the change of susceptibility rates to imipenem, ceftriaxone, cefepime, piperacillin/tazobactam, and ciprofloxacin over time and the relationship to antibiotic use for the period 2000-2006. Antibiotic use-susceptibility relationships were assessed using longitudinal regression analysis. The variables "time" and define daily doses (DDD)/1,000 patient days for the specific drug related to the susceptibility rates of that particular model's dependent variable were considered as the main effects, with significance determined at the 0.05 level. Decreases in susceptibility of the target organisms were common over the period of observation. Decreasing susceptibility trends over time were not statistically associated with the primary drug (e.g., organism susceptibility rate to imipenem with imipenem usage). However, secondary drug use was associated with susceptibility rates (e.g., susceptibility of E. cloacae to cefepime with piperacillin/tazobactam usage). These results suggest that antibiotic use-resistance relationships are influenced by the use of secondary antibiotics. Thus, a resistance problem may not be adequately addressed by simply altering the utilization of the primary antibiotic.

摘要

我们以铜绿假单胞菌、大肠埃希菌、肺炎克雷伯菌和阴沟肠杆菌的药敏率随时间的变化为指标,评估了 2000 年至 2006 年期间,时间和特定药物的定义日剂量(DDD)/1000 患者日与药敏率的关系,以评估药敏率随时间的变化与抗生素使用之间的相关性。采用纵向回归分析评估抗生素使用-药敏关系。主要影响因素为“时间”和与特定模型的因变量药敏率相关的特定药物的 DDD/1000 患者日,显著水平为 0.05。在观察期间,目标生物体的药敏率普遍下降。随着时间的推移,药敏率的下降趋势与主要药物(如亚胺培南的使用与亚胺培南的药敏率)没有统计学关联。然而,二线药物的使用与药敏率有关(如哌拉西林/他唑巴坦的使用与阴沟肠杆菌对头孢吡肟的药敏率)。这些结果表明,抗生素使用-耐药关系受到二线抗生素使用的影响。因此,仅仅改变主要抗生素的使用可能无法充分解决耐药问题。

相似文献

1
The association between antibiotic use and resistance: the role of secondary antibiotics.抗生素使用与耐药性之间的关联:次级抗生素的作用。
Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1125-9. doi: 10.1007/s10096-010-0972-5. Epub 2010 Jun 10.
2
[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].[中国重症监护病房医院革兰阴性杆菌耐药性的持续监测]
Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):375-81.
3
Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan.日本术后腹腔内感染分离出的常见病原体的抗菌药敏性
J Infect Chemother. 2018 May;24(5):330-340. doi: 10.1016/j.jiac.2018.02.011. Epub 2018 Mar 16.
4
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.2013 年至 2015 年期间,美国住院患者呼吸道标本中分离的铜绿假单胞菌和肠杆菌科细菌对头孢他洛滨-他唑巴坦的活性。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.02125-17. Print 2018 Mar.
5
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).北美MYSTIC项目(1999 - 2001年)中的抗菌药物使用与耐药趋势关系
J Antimicrob Chemother. 2004 Feb;53(2):290-6. doi: 10.1093/jac/dkh039. Epub 2004 Jan 7.
6
Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to β-lactams and carbapenems in patients with healthcare-associated infections.碳青霉烯类使用与医院获得性感染铜绿假单胞菌对β-内酰胺类和碳青霉烯类药物耐药率的相关性。
J Glob Antimicrob Resist. 2018 Jun;13:60-64. doi: 10.1016/j.jgar.2017.11.005. Epub 2017 Nov 14.
7
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany.在德国住院患者分离的铜绿假单胞菌和肠杆菌科细菌对头孢洛扎/他唑巴坦的体外活性。
Int J Antimicrob Agents. 2018 Feb;51(2):227-234. doi: 10.1016/j.ijantimicag.2017.06.024. Epub 2017 Jul 10.
8
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.2006 至 2010 年间,台湾 5 家持续参与监测抗菌药物耐药性趋势(SMART)研究的医疗中心的复杂腹腔内感染患者分离病原菌的药敏结果。
Int J Antimicrob Agents. 2012 Jun;40 Suppl:S29-36. doi: 10.1016/S0924-8579(12)70007-9.
9
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).头孢洛扎/他唑巴坦对亚太地区(不包括中国、澳大利亚和新西兰)引起的医疗保健相关感染的耐药肠杆菌科和铜绿假单胞菌的活性:来自抗菌监测计划(2013-2015 年)的报告。
Int J Antimicrob Agents. 2018 Feb;51(2):181-189. doi: 10.1016/j.ijantimicag.2017.09.016. Epub 2017 Oct 6.
10
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.多利培南对产超广谱β-内酰胺酶肠杆菌科和铜绿假单胞菌分离株的活性。
Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1179-81. doi: 10.1007/s10096-010-0974-3. Epub 2010 Jun 4.

引用本文的文献

1
New Agents Are Coming, and So Is the Resistance.新的病原体正在出现,耐药性问题也随之而来。
Antibiotics (Basel). 2024 Jul 13;13(7):648. doi: 10.3390/antibiotics13070648.
2
The Link between Purine Metabolism and Production of Antibiotics in .嘌呤代谢与……中抗生素产生之间的联系
Antibiotics (Basel). 2019 Jun 6;8(2):76. doi: 10.3390/antibiotics8020076.
3
Novel actinomycin group compound from newly isolated Streptomyces sp. RAB12: isolation, characterization, and evaluation of antimicrobial potential.新型放线菌素类化合物,来自新分离的链霉菌 RAB12:分离、鉴定和抗菌潜力评估。

本文引用的文献

1
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.一项针对非住院患者感染产超广谱β-内酰胺酶肠杆菌科细菌危险因素的多国调查。
Clin Infect Dis. 2009 Sep 1;49(5):682-90. doi: 10.1086/604713.
2
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.国家医疗安全网络年度更新:与医疗保健相关感染有关的抗菌药物耐药病原体:2006 - 2007年向疾病控制和预防中心国家医疗安全网络报告的数据年度总结
Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011. doi: 10.1086/591861.
3
Appl Microbiol Biotechnol. 2018 Feb;102(3):1241-1250. doi: 10.1007/s00253-017-8696-4. Epub 2017 Dec 21.
4
A cross sectional study on antibiotic resistance pattern of Salmonella typhi clinical isolates from Bangladesh.一项关于孟加拉国伤寒沙门氏菌临床分离株抗生素耐药模式的横断面研究。
Asian Pac J Trop Biomed. 2014 Apr;4(4):306-11. doi: 10.12980/APJTB.4.2014C770.
5
Antibiotic consumption and its influence on the resistance in Enterobacteriaceae.抗生素的使用及其对肠杆菌科细菌耐药性的影响。
BMC Res Notes. 2014 Jul 16;7:454. doi: 10.1186/1756-0500-7-454.
Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy.美国130家医院成人抗菌药物使用情况的测量:限定日剂量与治疗天数的比较。
Clin Infect Dis. 2007 Mar 1;44(5):664-70. doi: 10.1086/511640. Epub 2007 Jan 22.
4
First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.以色列首次对产超广谱β-内酰胺酶的大肠杆菌和克雷伯菌属进行抗菌药物敏感性全国监测。
Diagn Microbiol Infect Dis. 2007 Feb;57(2):201-5. doi: 10.1016/j.diagmicrobio.2006.07.011.
5
High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.产超广谱β-内酰胺酶肠杆菌科细菌中高水平的抗菌药物共耐药现象。
Antimicrob Agents Chemother. 2005 May;49(5):2137-9. doi: 10.1128/AAC.49.5.2137-2139.2005.
6
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.国家医院感染监测(NNIS)系统报告,1992年1月至2004年6月数据总结,2004年10月发布。
Am J Infect Control. 2004 Dec;32(8):470-85. doi: 10.1016/S0196655304005425.
7
Does increased use of antibiotics result in increased antibiotic resistance?抗生素使用的增加是否会导致抗生素耐药性增加?
Clin Infect Dis. 2004 Jul 1;39(1):18-9. doi: 10.1086/420826. Epub 2004 Jun 1.
8
Testing for serial correlation in least squares regression. II.最小二乘回归中的序列相关性检验。II.
Biometrika. 1951 Jun;38(1-2):159-78.
9
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).北美MYSTIC项目(1999 - 2001年)中的抗菌药物使用与耐药趋势关系
J Antimicrob Chemother. 2004 Feb;53(2):290-6. doi: 10.1093/jac/dkh039. Epub 2004 Jan 7.
10
Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.1991 - 2000年美国10家教学医院中氟喹诺酮类药物使用与特定病原体对氟喹诺酮类药物敏感性变化之间的关系。
Clin Infect Dis. 2003 Dec 15;37(12):1643-8. doi: 10.1086/379709. Epub 2003 Nov 20.